DYNACURE
Description:
- Biotechnology company developing new treatments for patients with severe orphan disorders.
- In its first drug discovery program, Dynacure focuses on centronuclear myopathies (CNM), a rare and debilitating disease that affects children and young adults.
At the origin of the project
- Jocelyn LAPORTE, Belinda COWLING and Hichem TASFAOUT
- IGBMC (Institute of Genetics and Molecular and Cellular Biology)
- CNRS - INSERM - University of Strasbourg